Andrew Kim
Pain Medicine · Las Vegas, NVNPI 1417100918
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 406 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 54 manufacturers reported payments, led by Boston Scientific at 32.7% of the total. Reporting peaked in 2019 at $2,448 and has fallen 60.0% since, to $978 in 2025.
Across 406 payments — averaging $27.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Medtronic$991
- Scilex Pharmaceuticals Inc.$706
- Biotronik NRO, Inc.$475
- Vertos Medical, Inc.$452
- Flowonix Medical Incorporated$426
- plus $4K from 48 others
Across 10 payments — averaging $5820.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Anika Therapeutics, Inc.$50K
- AbbVie$8K
- Medtronic$230
What the payments were for
- Travel & lodging$2502%
- Food & beverage$10,74298%
- Education$40%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL PAIN MANAGEMENT$963
- Prometra II$369
- Superion ISS$248
- mild Device Kit$210
- Prolate$207
- Nalocet$207
- SYNCHROMEDII$185
- GENERAL BIOPSY$153
- WaveWriter Alpha Prime 16$149
- Prospera$144
- SPECTRA WAVEWRITER$140
- Puraply, NuShield, Affinity$125
- Evoke$117
- ELIQUIS$116
How this compares
$10,996 in reported general payments places this provider in the 80th percentile of 101 pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 182 | $4,039 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 116 | $3,504 |
| Morphine Sulfate ErMorphine Sulfate | 29 | $2,405 |
| Lidocaine | 17 | $2,260 |
| Celecoxib | 42 | $1,679 |
| Oxycodone Hcl | 73 | $1,474 |
| Gabapentin | 109 | $756 |
| Tramadol Hcl | 94 | $723 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 41 | $543 |
| Pregabalin | 35 | $413 |
| Hydromorphone Hcl | 12 | $310 |
| Baclofen | 41 | $234 |
| Tizanidine Hcl | 30 | $201 |
| Lorazepam | 12 | $156 |
| Zolpidem Tartrate | 13 | $150 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Las Vegas
- Kunal ParikhLas Vegas$26K
- Nader HelmiLas Vegas$25K
- Sungkook ParkLas Vegas$20K
- Pouya MohajerLas Vegas$17K
- David AlvaradoLas Vegas$15K
- Okwuchukwu ObiLas Vegas$15K
- Christopher FisherLas Vegas$13K
- Neville CampbellLas Vegas$11K
- Heerak KangLas Vegas$11K
- Ruben AlexanderLas Vegas$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.